EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antibodies targeting ADAM17 reverse neurite outgrowth inhibition by myelin-associated inhibitors

Nayanendu Saha iD, Eric Chan, Rachelle P Mendoza, Yevgeniy Romin, Murray J Tipping iD, Dimitar B Nikolov iD

Life Science Alliance · 2025-06 · 8 (6) · e202403126

DOI: 10.26508/lsa.202403126 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Science Alliance, online erschienen am 25.03.2025. Verfasst von Nayanendu Saha und 5 weiteren Autor:innen. Beteiligte Einrichtung: Structural Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA sahan@mskcc.org. Hauptthemen laut MEDLINE: ADAM17 Protein, Neuronal Outgrowth, Antibodies, Monoclonal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIA NIH HHS, New York State Spinal Cord Injury Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Upon spinal cord injury, axons attempting to regenerate need to overcome the repulsive actions of myelin-associated inhibitors, including the myelin-associated glycoprotein, Nogo-A, and the oligodendrocyte myelin glycoprotein. These inhibitors bind and signal through a neuronal receptor/co-receptor/transducer complex composed of NgR1, Lingo-1, and p75. Consequently, p75 is cleaved by alpha secretase followed by gamma-secretase, triggering downstream signaling that inhibits axonal regrowth. ADAM10 and ADAM17 are both known to function as alpha secretases in neurons. Here we show that ADAM17, and not ADAM10, is the alpha secretase that recognizes and cleaves p75, when it is a part of a 5-component neuron-myelin signaling complex comprising NgR1, Lingo-1, p75, GT1b, and a myelin inhibitor. Importantly, we demonstrate the ability of inhibitory anti-ADAM17 mAbs to abrogate the cleavage of p75 in a neuroblastoma-glioma cell line and reverse the neurite outgrowth inhibition by myelin-associated inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ADAM17 ProteinNeuronal OutgrowthAntibodies, MonoclonalAnimalsHumansMyelin SheathAmyloid Precursor Protein SecretasesMembrane ProteinsCell Line, TumorNogo ProteinsMyelin-Associated GlycoproteinNeuritesMyelin ProteinsReceptor, Nerve Growth FactorADAM10 ProteinNerve Tissue ProteinsMiceSpinal Cord InjuriesNogo Receptor 1RatsNeuronsMyelin-Oligodendrocyte GlycoproteinAxons

Substanzen

ADAM17 ProteinAmyloid Precursor Protein SecretasesMembrane ProteinsNogo ProteinsMyelin-Associated GlycoproteinMyelin ProteinsAntibodies, MonoclonalReceptor, Nerve Growth FactorADAM17 protein, humanADAM10 Protein

Autor:innen und Institutionen

  • Structural Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA sahan@mskcc.org.
  • Molecular Cytology Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, USA.
  • Structural Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA nikolovd@mskcc.org.

ORCID-Profile: Nayanendu Saha, Murray J Tipping, Dimitar B Nikolov

Förderung

  • NCI NIH HHS
  • NIA NIH HHS
  • New York State Spinal Cord Injury Research Program
  • National Institutes of Health
  • NIH/NCI Cancer Center Support Grant to MSKCC

Zitieren

APA

Saha, N., Chan, E., Mendoza, R. P., Romin, Y., Tipping, M. J., & Nikolov, D. B. (2025). Antibodies targeting ADAM17 reverse neurite outgrowth inhibition by myelin-associated inhibitors. Life Science Alliance, 8(6), e202403126. https://doi.org/10.26508/lsa.202403126

Vancouver

Saha N, Chan E, Mendoza RP, Romin Y, Tipping MJ, Nikolov DB. Antibodies targeting ADAM17 reverse neurite outgrowth inhibition by myelin-associated inhibitors. Life Science Alliance. 2025;8(6):e202403126. doi:10.26508/lsa.202403126

BibTeX
@article{Saha2025,
  author = {Saha, Nayanendu and Chan, Eric and Mendoza, Rachelle P and Romin, Yevgeniy and Tipping, Murray J and Nikolov, Dimitar B},
  title = {Antibodies targeting ADAM17 reverse neurite outgrowth inhibition by myelin-associated inhibitors},
  journal = {Life Science Alliance},
  year = {2025},
  volume = {8},
  number = {6},
  pages = {e202403126},
  doi = {10.26508/lsa.202403126}
}
Kostenlos starten →